Skip to main content

Table 1 Baseline clinical characteristics of patients with ischemic heart disease with bone marrow cells transplantation and control group without transplantation

From: Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease

 

IHD with BMCs-Tx(n=12)

IHD without BMCs-Tx(n=12)

P

Age

62 ± 6

60 ± 5

NS

m/f

8/4

9/3

NS

Cardiovascular Risk Factors (%)

   

Hypertension

70

65

NS

Hyperlipidemia

60

60

NS

Smoking

80

75

NS

Diabetes

30

30

NS

Positive family history of CAD

20

15

NS

Transmural myocardial infarction, months before Tx

20 ± 8

24 ± 8

NS

No. of diseased vessels

2 ± 0.8

2 ± 0.8

NS

Infarct-related vessel (LAD/LCX/RCA)

10/0/2

9/0/3

NS

Time from symptom onset to first reperfusion therapy (hr)

6 ± 5

6 ± 4

NS

Primary reperfusion therapy (%)

100

100

NS

PTCA/Stent at the time of AMI

12/12

12/12

NS

Medication (%)

   

Aspirin

100

100

NS

Clopidogrel

100

100

NS

ACE inhibitor or AT II blocker

100

100

NS

Beta-blocker

100

100

NS

Aldosterone Antagonist

25

25

NS

Statin

100

100

NS

Laboratory parameters

   

CPK U/L

2010 ± 540

2145 ± 670

NS

  1. Ischemic heart disease (IHD), Bone marrow cells transplantation (BMCs-Tx), Coronary artery disease (CAD), Percutaneous transluminal coronary angioplasty (PTCA), Creatine phosphokinase (CPK), Left anterior descending coronary artery (LAD), Left circumflex artery (LCX), Right coronary artery (RCA), None significant (NS).